These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29069710)

  • 41. Nasolacrimal duct office probing in children under the age of 12 months: Cure rate and cost evaluation.
    Le Garrec J; Abadie-Koebele C; Parienti JJ; Molgat Y; Degoumois A; Mouriaux F
    J Fr Ophtalmol; 2016 Feb; 39(2):171-7. PubMed ID: 26826746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Success of probing for congenital nasolacrimal duct obstruction in children under 10 years of age.
    Thongthong K; Singha P; Liabsuetrakul T
    J Med Assoc Thai; 2009 Dec; 92(12):1646-50. PubMed ID: 20043568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraoperative prognostic factors for probing outcome in children with congenital nasolacrimal duct obstruction.
    Andalib D; Nabei R
    Eur J Ophthalmol; 2013; 23(3):329-32. PubMed ID: 23225091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Factors affected therapeutic results in treatment of children congenital nasolacrimal duct obstruction by Ritleng lacrimal intubation].
    Yu G; Hu M; Wu Q; Cao WH; Fan YW; Lin Q; Liu W
    Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):423-7. PubMed ID: 22932332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction.
    Leibovitch I; Selva D; Tsirbas A; Greenrod E; Pater J; Wormald PJ
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1250-4. PubMed ID: 16538447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tobramycin/dexamethasone eye drops as a better choice for lacrimal duct probing in persistent congenital nasolacrimal duct obstruction: A consort study.
    Xiang Q; Hu D; Gao X
    Medicine (Baltimore); 2019 Feb; 98(6):e14188. PubMed ID: 30732134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Pushed" stent intubation for treatment of complex congenital nasolacrimal duct obstruction.
    Eshraghi B; Aghajani A; Kasaei A; Tabatabaei Z; Akbari M; Fard MA
    Eur J Ophthalmol; 2014; 24(5):650-4. PubMed ID: 24729146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of endoscopic dacryocystorhinostomy: Experience of a fellowship trainee at a tertiary care center.
    Kamal S; Ali MJ; Nair AG
    Indian J Ophthalmol; 2016 Sep; 64(9):648-653. PubMed ID: 27853012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficiency of endoscopic imaging in repetitive probing following unsuccessful probing.
    Okumus S; Gürler B; Coskun E; Durucu C; Tatar MG; Yayuspayi R; Durucu E; Erbagci I
    Eur J Ophthalmol; 2012; 22(6):882-9. PubMed ID: 22562295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes Associated with Indwelling Momentary Probe for Congenital Nasolacrimal Duct Obstruction Treatment.
    Han X; Bian Y; Yu B
    J Coll Physicians Surg Pak; 2022 Dec; 32(12):1581-1585. PubMed ID: 36474379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of the Masterka for complex nasolacrimal duct obstruction in children.
    Khatib L; Nazemzadeh M; Revere K; Katowitz WR; Katowitz JA
    J AAPOS; 2017 Oct; 21(5):380-383. PubMed ID: 28917994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?
    Kashkouli MB; Beigi B; Parvaresh MM; Kassaee A; Tabatabaee Z
    Br J Ophthalmol; 2003 Sep; 87(9):1151-3. PubMed ID: 12928286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late probing for congenital nasolacrimal duct obstruction.
    Maheshwari R; Maheshawri S
    J Coll Physicians Surg Pak; 2007 Jan; 17(1):41-3. PubMed ID: 17204219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoscopic intranasal surgery for congenital nasolacrimal duct obstruction--a new approach.
    Korkmaz H; Korkmaz M; Karakahya RH; Serhatlı M
    Int J Pediatr Otorhinolaryngol; 2013 Jun; 77(6):918-21. PubMed ID: 23541294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Success rate of late primary probing in congenital nasolacrimal duct obstruction.
    Rajabi MT; Abrishami Y; Hosseini SS; Tabatabaee SZ; Rajabi MB; Hurwitz JJ
    J Pediatr Ophthalmol Strabismus; 2014; 51(6):360-2. PubMed ID: 25215516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The results of late probing in congenital nasolacrimal duct obstruction.
    Zilelioğlu G; Hoşal BM
    Orbit; 2007 Mar; 26(1):1-3. PubMed ID: 17510863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors affecting treatment outcome in congenital nasolacrimal duct obstruction: A retrospective analysis from South India.
    Bhandari S; Sengupta S; Yadalla D; Rajagopalan J; Velis GB; Talele D; Kushwaha S
    Indian J Ophthalmol; 2015 Oct; 63(10):759-62. PubMed ID: 26654998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of congenital lacrimal duct obstruction: A prospective clinical cohort study].
    Heichel J; Bachner F; Schmidt-Pokrzywniak A; Struck HG; Stuhlträger U; Bredehorn-Mayr T
    Ophthalmologe; 2015 Oct; 112(10):840-7. PubMed ID: 26070835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. External versus endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction in a tertiary referral center.
    Ben Simon GJ; Joseph J; Lee S; Schwarcz RM; McCann JD; Goldberg RA
    Ophthalmology; 2005 Aug; 112(8):1463-8. PubMed ID: 15953636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of probing under topical anesthesia in children below 18 months of age with congenital nasolacrimal duct obstruction.
    Shrestha JB; Bajimaya S; Hennig A
    Nepal Med Coll J; 2009 Mar; 11(1):46-9. PubMed ID: 19769238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.